FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205123093> ?p ?o ?g. }

• W4205123093 abstract "Background: There is controversy over whether use of new oral anticoagulants (NOACs) associates with increased hemorrhage risk compared with non-NOAC. Meanwhile, determining which NOAC to use remains unclear. We aimed to summarize the evidence about NOACs in venous thromboembolism (VTE) prevention for patients with total hip and knee arthroplasty (THA and TKA). Methods: We searched RCTs assessing NOACs for VTE prophylaxis in adults undergoing THA and TKA in Medline, Embase, and Cochrane up to May 2021. Primary outcomes were VTE [included deep vein thrombosis (DVT) and pulmonary embolism (PE)], major VTE, and major bleeding. The rank probabilities of each treatment were summarized by the surface under the cumulative ranking curve area (SUCRA). Results: 25 RCTs with 42,994 patients were included. Compared with non-NOAC, NOACs were associated with a decreased risk of VTE (RR 0.68; 95% CI 0.55-0.84) and major VTE (RR = 0.52; 95% CI 0.35-0.76). Additionally, rivaroxaban, apixaban, and edoxaban but not dabigatran and betrixaban, did confer a higher efficacy compared with non-NOAC. None of the individual NOACs increased the risk of bleeding, while apixaban and betrixaban were even associated with a decreased risk of bleeding. In the comparison of different NOACs, rivaroxaban was associated with the greatest benefits in VTE (SUCRA = 79.6), DVT (SUCRA = 88.8), and major VTE (SUCRA = 89.9) prevention. Furthermore, subgroup analysis confirmed that NOACs associated with a higher efficacy tendency in patients with follow-up duration <60 days than follow-up duration ≥60 days. Conclusion: Evidence suggests that NOACs exert more benefits on VTE prophylaxis, and none of the individual NOACs increased hemorrhage compared with non-NOAC. Among various NOACs, rivaroxaban is recommended in patients with lower bleeding risk, and apixaban is recommended in patients with higher bleeding risk. Systematic Review Registration: [https://www.crd.york.ac.uk/prospero/], identifier [CRD42021266890]." @default.
• W4205123093 created "2022-01-25" @default.
• W4205123093 creator A5004753628 @default.
• W4205123093 creator A5023236088 @default.
• W4205123093 creator A5048918957 @default.
• W4205123093 creator A5049888431 @default.
• W4205123093 creator A5082391468 @default.
• W4205123093 creator A5083443028 @default.
• W4205123093 date "2022-01-17" @default.
• W4205123093 modified "2023-09-30" @default.
• W4205123093 title "New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis" @default.
• W4205123093 cites W1860620208 @default.
• W4205123093 cites W1973068188 @default.
• W4205123093 cites W1985842169 @default.
• W4205123093 cites W2000438765 @default.
• W4205123093 cites W2003726612 @default.
• W4205123093 cites W2010074616 @default.
• W4205123093 cites W2014491911 @default.
• W4205123093 cites W2023106976 @default.
• W4205123093 cites W2030368027 @default.
• W4205123093 cites W2036506340 @default.
• W4205123093 cites W2067118403 @default.
• W4205123093 cites W2097162401 @default.
• W4205123093 cites W2105320272 @default.
• W4205123093 cites W2107205214 @default.
• W4205123093 cites W2114189419 @default.
• W4205123093 cites W2115348966 @default.
• W4205123093 cites W2125435699 @default.
• W4205123093 cites W2133686162 @default.
• W4205123093 cites W2135230339 @default.
• W4205123093 cites W2146962811 @default.
• W4205123093 cites W2150567120 @default.
• W4205123093 cites W2151252098 @default.
• W4205123093 cites W2157361201 @default.
• W4205123093 cites W2167245867 @default.
• W4205123093 cites W2282294815 @default.
• W4205123093 cites W2398171321 @default.
• W4205123093 cites W2441750859 @default.
• W4205123093 cites W2529040403 @default.
• W4205123093 cites W2549557285 @default.
• W4205123093 cites W2586961766 @default.
• W4205123093 cites W2743119623 @default.
• W4205123093 cites W2782300751 @default.
• W4205123093 cites W2788601536 @default.
• W4205123093 cites W2792857103 @default.
• W4205123093 cites W2803360066 @default.
• W4205123093 cites W2898079850 @default.
• W4205123093 cites W2900722030 @default.
• W4205123093 cites W2911512725 @default.
• W4205123093 cites W2946478867 @default.
• W4205123093 cites W2966473932 @default.
• W4205123093 cites W2969518214 @default.
• W4205123093 cites W3003777732 @default.
• W4205123093 cites W3016782834 @default.
• W4205123093 cites W3087282810 @default.
• W4205123093 cites W3128852645 @default.
• W4205123093 cites W3153799517 @default.
• W4205123093 doi "https://doi.org/10.3389/fphar.2021.775126" @default.
• W4205123093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35111051" @default.
• W4205123093 hasPublicationYear "2022" @default.
• W4205123093 type Work @default.
• W4205123093 citedByCount "5" @default.
• W4205123093 countsByYear W42051230932022 @default.
• W4205123093 countsByYear W42051230932023 @default.
• W4205123093 crossrefType "journal-article" @default.
• W4205123093 hasAuthorship W4205123093A5004753628 @default.
• W4205123093 hasAuthorship W4205123093A5023236088 @default.
• W4205123093 hasAuthorship W4205123093A5048918957 @default.
• W4205123093 hasAuthorship W4205123093A5049888431 @default.
• W4205123093 hasAuthorship W4205123093A5082391468 @default.
• W4205123093 hasAuthorship W4205123093A5083443028 @default.
• W4205123093 hasBestOaLocation W42051230931 @default.
• W4205123093 hasConcept C126322002 @default.
• W4205123093 hasConcept C141071460 @default.
• W4205123093 hasConcept C2776265017 @default.
• W4205123093 hasConcept C2776301958 @default.
• W4205123093 hasConcept C2778661090 @default.
• W4205123093 hasConcept C2778810321 @default.
• W4205123093 hasConcept C2778959117 @default.
• W4205123093 hasConcept C2779161974 @default.
• W4205123093 hasConcept C2780011451 @default.
• W4205123093 hasConcept C2780290652 @default.
• W4205123093 hasConcept C2780638905 @default.
• W4205123093 hasConcept C2780868729 @default.
• W4205123093 hasConcept C2991741193 @default.
• W4205123093 hasConcept C71924100 @default.
• W4205123093 hasConceptScore W4205123093C126322002 @default.
• W4205123093 hasConceptScore W4205123093C141071460 @default.
• W4205123093 hasConceptScore W4205123093C2776265017 @default.
• W4205123093 hasConceptScore W4205123093C2776301958 @default.
• W4205123093 hasConceptScore W4205123093C2778661090 @default.
• W4205123093 hasConceptScore W4205123093C2778810321 @default.
• W4205123093 hasConceptScore W4205123093C2778959117 @default.
• W4205123093 hasConceptScore W4205123093C2779161974 @default.
• W4205123093 hasConceptScore W4205123093C2780011451 @default.
• W4205123093 hasConceptScore W4205123093C2780290652 @default.
• W4205123093 hasConceptScore W4205123093C2780638905 @default.
• W4205123093 hasConceptScore W4205123093C2780868729 @default.
• W4205123093 hasConceptScore W4205123093C2991741193 @default.
• W4205123093 hasConceptScore W4205123093C71924100 @default.

• next